Paul L Berns - Title: Chief Executive Officer and Chairman of the Board, Director at Neumora Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Title: Chief Executive Officer and Chairman of the Board, Director
Issuer Symbol
NMRA on Nasdaq
All Insider Reports
All Insider Reports

Paul L Berns - trading volume in the past year for Neumora Therapeutics, Inc.

Holdings reported by Paul L Berns for Neumora Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 7,395,185 $25,952,662 $3.51 17 Feb 2026 Direct
Common Stock 133,097 $271,517 $2.04 17 Feb 2026 Indirect
Stock Option (Right to Buy) 1,650,000 08 Jan 2026 Direct Common Stock

Transactions reported by Paul L Berns for Neumora Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.